Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

Neurology

Volumn 54, Issue 5, 2000, Pages 1166-1175

  Gross, Paul T ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Dependence; Modafinil; Narcolepsy; Performance; Sleepiness; Somnolence; Wakefulness; Withdrawal

Indexed keywords

MODAFINIL; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE;

EID: 0342545934     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.5.1166     Document Type: Article

References (34)

1. Guilleminault C. Narcolepsy syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 2nd ed. Philadelphia: Saunders, 1994:549-561.
2. Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994;17:S60-S67.
3. Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet 1989;12:1376-1379.
4. Mitler MM, Dement WC. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. Electroencephalogr Clin Neurophysiol 1977;43:691-699.
5. Nishino S, Reid MS, Dement WC, Mignot E. Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 1994;17: S84-S92.
6. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.
7. Mitler MM, Aldrich MS, Koob GF, Zarcone VP. Narcolepsy and its treatment with stimulants. ASDA Standards of Practice. Sleep 1994;17:352-371.
8. Parkes J. Amphetamines and alertness. In: Guilleminault C, Dement W, Pasouant P, eds. Narcolepsy. New York: Spectrum Publications, 1976:643-658.
9. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman's The pharmacological basis of therapeutics. Ninth edition. New York, NY: McGraw-Hill, 1996:557-577.
10. Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992;591:319-326.
11. Mignot E, Nishino S, Guilleminault C, Dement WC. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994;17:436-437.
12. Simon P, Hemet C, Ramassamy C, Costentin J. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 1995;5:509-514.
13. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996;93:14128-14133.
14. Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV. Differential patterns of regional c-fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998;241:95-98.
15. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451.
16. Siegel JM. Narcolepsy: a key role for hypocretins (orexins). Cell 1999;98:409-412.
17. Sakurai T, Moriguchi T, Furuya K, et al. Structure and function of human prepro-orexin gene. J Biol Chem 1999;274: 17771-17776.
18. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999;19:3171-3182.
19. US Modafinil in Narcolepsy Multicenter Study Group. Modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
20. Broughton RJ, Fleming JA, George CF, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-451.
21. Thorpy MJ. The International Classification of Sleep Disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990.
22. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-524.
23. Mitler MM, Gujavarty KS, Browman CP. Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982;53:658-661.
24. Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the Maintenance of Wakefulness Test (MWT). Electroencephalogr Clin Neurophysiol 1997;103:554-562.
25. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540-545.
26. Guy W. ECDEU Assessment manual for psychopharmacology (revised). Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institutes of Mental Health, Pharmacology Branch, 1976.
27. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: BIS/BRI, UCLA, 1968.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
29. Gold LH, Balster RL. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) 1996;126:286-292.
30. Warot D, Corruble E, Payan C, Weil JS, Puech AJ. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur Psychiatry 1993;8:201-208.
31. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 2000 (in press).
32. Mitler MM, Hajdukovic RM, Erman M, Koziol JA. Narcolepsy. J Clin Neurophysiol 1990;7:93-118.
33. Mitler MM, Hajdukovic RM, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep 1996;16:306-317.
34. Dahmen N, Querings K, Grün B, Bierbrauer J. Increased frequency of migraine in narcoleptic patients. Neurology 1999; 52:1291-1293.